These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6389718)

  • 1. Prevention of fatal experimental burn-wound sepsis due to Klebsiella pneumoniae KP1-O by immunization with homologous capsular polysaccharide.
    Cryz SJ; Fürer E; Germanier R
    J Infect Dis; 1984 Dec; 150(6):817-22. PubMed ID: 6389718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against fatal Klebsiella pneumoniae burn wound sepsis by passive transfer of anticapsular polysaccharide.
    Cryz SJ; Fürer E; Germanier R
    Infect Immun; 1984 Jul; 45(1):139-42. PubMed ID: 6376353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental Klebsiella pneumoniae burn wound sepsis: role of capsular polysaccharide.
    Cryz SJ; Fürer F; Germanier R
    Infect Immun; 1984 Jan; 43(1):440-1. PubMed ID: 6360907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and immunogenicity of Klebsiella pneumoniae K1 capsular polysaccharide vaccine in humans.
    Cryz SJ; Fürer E; Germanier R
    J Infect Dis; 1985 Apr; 151(4):665-71. PubMed ID: 3882856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection with bacteriophage KØ1 against fatal Klebsiella pneumoniae-induced burn wound infection in mice.
    Malik R; Chhibber S
    J Microbiol Immunol Infect; 2009 Apr; 42(2):134-40. PubMed ID: 19597645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization against fatal experimental Klebsiella pneumoniae pneumonia.
    Cryz SJ; Fürer E; Germanier R
    Infect Immun; 1986 Nov; 54(2):403-7. PubMed ID: 3533779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of intravenous immune globulins against Klebsiella.
    Cryz SJ; Cross AS; Fürer E; Chariatte N; Sadoff JC; Germanier R
    J Lab Clin Med; 1986 Sep; 108(3):182-9. PubMed ID: 3746094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine immunoprotective activity of Klebsiella pneumoniae cell surface preparations: comparative study with ribosomal preparations.
    Fournier JM; Jolivet-Reynaud C; Riottot MM; Jouin H
    Infect Immun; 1981 May; 32(2):420-6. PubMed ID: 7019071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and vaccine potential of Klebsiella capsular polysaccharides.
    Cryz SJ; Fürer E; Germanier R
    Infect Immun; 1985 Oct; 50(1):225-30. PubMed ID: 4044036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenic properties of Klebsiella pneumoniae type 2 capsular polysaccharide.
    Robert A; Jouin H; Fournier JM
    Infect Immun; 1986 Nov; 54(2):365-70. PubMed ID: 3095240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against fatal Klebsiella pneumoniae sepsis in the squirrel monkey Saimiri sciureus after immunization with a capsular polysaccharide vaccine.
    Postal JM; Gysin J; Crenn Y
    Ann Inst Pasteur Immunol; 1988; 139(4):401-7. PubMed ID: 3048318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of immunoprotection against fatal experimental Klebsiella pneumoniae pneumonia].
    Shimoguchi K
    Kansenshogaku Zasshi; 1990 Dec; 64(12):1482-92. PubMed ID: 2074365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoprotective activity of capsular polysaccharide in Klebsiella pneumoniae ribosomal preparations does not involve ribonucleic acid.
    Riottot MM; Fournier JM
    Infect Immun; 1981 Oct; 34(1):126-30. PubMed ID: 6170582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct evidence for the involvement of capsular polysaccharide in the immunoprotective activity of Klebsiella pneumoniae ribosomal preparations.
    Riottot MM; Fournier JM; Jouin H
    Infect Immun; 1981 Jan; 31(1):71-7. PubMed ID: 7012008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of a polyvalent Klebsiella capsular polysaccharide vaccine in humans.
    Cryz SJ; Mortimer P; Cross AS; Fürer E; Germanier R
    Vaccine; 1986 Mar; 4(1):15-20. PubMed ID: 3962447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against fatal Pseudomonas aeruginosa burn wound sepsis by immunization with lipopolysaccharide and high-molecular-weight polysaccharide.
    Cryz SJ; Fürer E; Germanier R
    Infect Immun; 1984 Mar; 43(3):795-9. PubMed ID: 6698608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against fatal Pseudomonas aeruginosa sepsis by immunization with smooth and rough lipopolysaccharides.
    Cryz SJ; Meadow PM; Fürer E; Germanier R
    Eur J Clin Microbiol; 1985 Apr; 4(2):180-5. PubMed ID: 3924605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Capsular polysaccharide of Klebsiella pneumoniae. II. Immunogenic properties].
    Alcántar-Curiel MD; Martínez-Ramos A; García-Latorre E
    Rev Latinoam Microbiol; 1993; 35(1):109-15. PubMed ID: 8140330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa.
    Hegerle N; Choi M; Sinclair J; Amin MN; Ollivault-Shiflett M; Curtis B; Laufer RS; Shridhar S; Brammer J; Toapanta FR; Holder IA; Pasetti MF; Lees A; Tennant SM; Cross AS; Simon R
    PLoS One; 2018; 13(9):e0203143. PubMed ID: 30188914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A murine monoclonal antibody against Klebsiella capsular polysaccharide is opsonic in vitro and protects against experimental Klebsiella pneumoniae infection.
    Trautmann M; Cryz SJ; Sadoff JC; Cross AS
    Microb Pathog; 1988 Sep; 5(3):177-87. PubMed ID: 3063912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.